Research on leishmaniasis is ongoing in both the civilian and military sectors including:
- Military Infectious Diseases Research Program (MIDRP)
- Responsible for managing DoD research on naturally occurring infectious diseases including leishmaniasis.)
- Uniformed Services University of the Health Sciences, Department of Medicine, Medical Research Laboratory of Naomi E. Aronson M.D., Infectious Diseases Division
- This laboratory is working on using laboratory discoveries on the immunology of the Leishmania parasite to develop an effective human vaccine for the prevention of leishmaniasis and to improve the treatment of the disease.
- Department of Defense Protocol for the Use of Sodium Stibogluconate (Pentostam®) as a Treatment for Leishmaniasis (ClinicalTrial.gov # NCT00657618
- The primary objective of this protocol is to collect safety and efficacy data on the use of Pentostam for treatment of laboratory-confirmed leishmaniasis (all three forms). The estimated completion date for this study, which started in October 2004, is December 2017.